We Dissect Protocols

Iptt 300

Manufactured by Avidity Science
147 citations
Sourced in United States
About the product

The IPTT-300 is a temperature transponder that can be used to monitor the temperature of small laboratory animals. It is a compact and lightweight device that can be implanted subcutaneously or injected into the animal. The IPTT-300 transmits the temperature data wirelessly, allowing for non-invasive temperature monitoring.

Automatically generated - may contain errors

Market Availability & Pricing

The IPTT-300, an implantable bio transponder, is not currently listed on the manufacturer's official website or catalog. There is no explicit confirmation regarding its availability or discontinuation status. Avidity Science, the original manufacturer, was acquired by ATS Corporation in November 2023.

Given the lack of official information, we cannot confirm the current commercial status of the IPTT-300. For the most accurate and up-to-date details, it is recommended to contact Avidity Science directly through their technical support channels.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

147 protocols using «iptt 300»

1

Thermoregulation in Maternal Mice

2025
8–10 weeks of age C57BL/6 background wild type female mice were implanted with a telemetry probe (IPTT-300, BioMedic Data Systems) underneath the skin to measure body temperature. All the mice were randomized into two groups. One group were bred with male mice to generate pregnant mice, lactating mice and RE mice. The other group served as age-matched littermate controls. These female mice were subjected to thermogradient box test on the 16th day of gestation (G16), the 6th day of lactation (PPD6) and 1 months after pups weaning (PW4w). PPD6 dams were separated from the pups just prior to the test. Briefly, mice were placed in a thermal gradient test box (Bio-TGT2, Bioseb) with one side set to 10 °C and the other side set to 50 °C for 30 min habituation followed by 30 min recording. The time spent in temperature zones was recorded and analyzed using Thermal Gradient Test software (Bioseb). The preferred temperature is the zone temperature in which mice spent longest time throughout the whole recording. On the day of thermogradient box test on G16, vaginal cells of the virgin female mice were flushed and observed under a light microscope to estimate estrous phases based on the proportion of leucocytes, cornified epithelial cells and nucleated epithelial cells.
Another batch of singly caged RE mice (5–7 months after weaning of pups) were used for the behavior tests as described below, and their body temperatures were measured at 10 am using a thermometer probe (DIGI-Sense, Type J/K/T, thermocouple meter, WD-20250-91).
+ Open protocol
+ Expand
2

Influenza Pathogenesis in Ferret Model

2025
All animal procedures were approved by the Institutional Animal Care and Use Committee in an Association for Assessment and Accreditation of Laboratory Animal Care International-accredited facility (IACUC Protocol: 3182ROWFERC). Male ferrets (Triple F Farms, Sayre, PA), aged 10–18 months and seronegative for circulating influenza viruses were used. Experiments were conducted using 18 ferrets for each virus [CA (A/H1PDM09), KS (A/H3N2), BR (B/Victoria lineage), and PH (B/Yamagata lineage)]. Anesthetized ferrets were challenged intranasally with 4 × 105 FFU virus. Animals were monitored for 28 days for weight loss, fever, lethargy, sneezing, and dyspnea. Ferrets were weighed on Day 0 prior to challenge to establish a baseline and then daily for the first 10 days post-challenge and weekly thereafter through Day 28. Changes in weight were calculated as percentage loss or gain from Day 0. For fever calculation, a temperature transponder (IPTT-300; Bio Medic Data Systems [BMDS], Waterford, WI, USA) was implanted subcutaneously between the shoulder blades of each animal and read with a scanner (DAS-6007 IPTT Scanner System, BMDS). A baseline temperature (°F) was determined by the average temperature over 3 days prior to challenge. Temperatures were assessed daily for 10 days post-challenge, then weekly and fever was determined as any temperature greater or equal to 2°F above baseline. Ferrets were assessed daily for clinical signs. Lethargy was determined by the relative inactivity index (RII) from Day 0 through Day 7 post-challenge; this period allowed for lethargy calculation throughout the period of active replication in the ferret respiratory tract. The scoring system for activity assessment was calculated as follows: 0, alert and playful; 1, alert but playful only when stimulated; 2, alert but not playful when stimulated; and 3, neither alert nor playful when stimulated. Based on the daily scores for each animal in a group, a relative inactivity index was calculated as follows: Σ(Day 1 to Day 7) [score +1 ]n / Σ(Day 1 to Day 7)n, where n equals the total number of observations. A value of 1 was added to each base score so that a score of 0 could be divided by a denominator, resulting in an index value of 1.0. RII, sneezing and dyspnea were assessed each day prior to handling and sedation of the animals. Clinical signs assessment was consistent with previously established methods (32 (link), 33 (link)).
+ Open protocol
+ Expand
3

Thermoregulation in Estrogen Receptor Alpha Mice

2025
Female ERαflox/flox mice [106 (link)] (10-week) were anesthetized by isoflurane and received bilateral stereotaxic injections of AAV-Cre-GFP or AAV-GFP virus (200 nl, 5∗1012 GC/ml, UNC Gene Therapy Center) into the POA (ML +/−0.30, AP 0.48 mm, DV -5.40 mm). Meanwhile, all the mice were implanted with temperature probes (IPTT-300, BioMedic Data Systems) underneath the skin of the back to monitor body temperature. All the mice were single caged for the measurements of body weight, food intake and body temperature at 10 am or 5pm. 5 weeks after virus injection, these mice were subject to thermogradient box test.
+ Open protocol
+ Expand
4

Muscle Temperature Monitoring in Rats

2024
Changes in skeletal muscle temperature in response to predator-odor or control-odor stimuli were measured using surgically implanted temperature transponders (implantable programmable temperature transponder-300; IPTT-300, BioMedic Data Systems, Seaford, DE; calibrated range 32°-43°C); transponders were used that had showed high correlation compared with water-bath temperature (R 2 ≥ 0.97) as well as in vivo with rectal temperature in the physiological range (R 2 ≥ 0.97) (Wacker et al., 2012) (link). Transponders are 14 mm long and 2 mm in diameter, sufficiently small to surgically implant into the gastrocnemius muscle group bilaterally in rats. Transponders were implanted under surgical anesthesia, with 5% isoflurane for induction followed by 2-3% for maintenance. Animals were given 1 week to recover.
+ Open protocol
+ Expand

Corresponding organizations : Kent State University

5

Investigating Pharmacological Thermoregulation

2024
We next examined whether isoflurane or CHA activated the POA neurons through their pharmacologic effect or the resulting hypothermia by administering isoflurane or CHA to the wild-type mice while keeping their body temperature. The wild-type mice indwelling a wireless passive transponder (IPTT-300, BioMedic Data Systems, Inc., Seaford, DE, USA) were administered 1.5% isoflurane or 0.04 nmol (20 µM × 2 µL) of CHA. At the same time, the anesthesia chamber or home cage was immersed in the water bath (37 ± 1 °C) to keep the animals’ body temperature euthermic [8 (link)]. The control groups received room air or ACSF administration.
+ Open protocol
+ Expand

Top 5 most cited protocols using «iptt 300»

1

Hibernation Dynamics in Ground Squirrels

Male and female 13-lined ground squirrels, I. tridecemlineatus ranging from 150 to 300 g (at the time of capture) were caught from the wild by USDA licensed trappers (TLS Research, Bartlett, IL, USA) annually in August. Animal housing and experimental procedures followed the guidelines set by the NINDS animal care and use committee (ACUC). Once caught, the squirrels were brought to the NIH and kept in quarantine to be sure they contained no infectious agents. As a prophylactic measure, all incoming squirrels were treated with 0.05 ml/squirrel of Profender to kill any parasites (3 mg/kg emodepside + 12 mg/kg praziquantel). Each animal was briefly anesthetized with 5% isofluorane and injected subcutaneously in the intrascapular area with a sterile programmable temperature transponder (IPTT-300, Bio medic Data Systems) to allow daily monitoring of Tb without touching or disturbing the squirrel. While this system does not provide an exact measure of core Tb, it does provide a close estimate (±2–3°C) (data not shown); therefore, indicating the stage of hibernation in which the squirrels belonged. Ground squirrels were then housed in individual cages and fed water and standard rodent chow ad libitum. Animals were housed in the holding colony at 21°C under a 12 h light:12 h dark cycle until used for experimental purposes. To enable a natural transition into torpor, some squirrels were transferred to constant darkness in an environmental chamber held at 4–5°C. A red safe light (3–5 lux) was used when entering the chamber so as not to disturb torpid squirrels. Also, a heavy dark curtain was used to shield the shelves containing the cages and block the light and sound resulting from opening and closing the door to the environmental chamber. Once a squirrel was observed to descent into torpor, a small amount of saw dust was dropped on the back of the animal to be sure it did not move (arouse) in between monitoring periods. Tissues were collected from animals at six different stages of the hibernation cycle based on Tb, time, and respiration rate. ACR = active in the cold room for at least 3 days (Tb = 34–37°C). ACR animals were capable of entering torpor, but had not done so in the past 72 h and were chosen as the reference group to rule out environmental light and temperature effects. EN = entrance phase of torpor (18°C ≤ Tb ≤ 31°C) (animals were only harvested for an EN time point after at least two successive temperatures showed a declining Tb), ET = early torpor phase (Tb = 5–8°C for 1 day), LT = late torpor phase (Tb = 5–8°C for at least 5 days), E-AR = early arousal, spontaneously arousing from torpor with an increasing respiration rate ≥60/min and an increasing yet still reduced Tb (Tb = 9–12°C). The final phase IA = interbout arousal. These animals had previously been in deep torpor, but had since returned to normal Tb (Tb = 34–37°C).
To collect tissues at the desired time points, the squirrels were first anesthetized with 5% isofluorane and the rectal temperature was measured to verify the accuracy of the temperature transponder. The animal was then decapitated with a guillotine. The desired tissues were removed quickly, rinsed with ice-cold phosphate-buffered saline (PBS) and frozen instantly in 2-methylbutane chilled with dry ice (−50°C) and then stored in a −70°C freezer until use.
+ Open protocol
+ Expand

Corresponding organizations : National Institutes of Health

2

Cytokine Measurement and Temperature Monitoring in LPS-Induced Endotoxic Shock

For cytokine measurements, mice were treated intraperitoneally with OI (50 mg kg−1) in 40% cyclodextrin in PBS or vehicle control for 2 h before stimulation with LPS (Sigma; 2.5 mg kg−1) intraperitoneally for 2 h. Mice were euthanized in a CO2 chamber, blood samples were collected and serum was isolated. Cytokines were measured using R&D ELISA kits according to manufacturer’s protocol. For temperature recording, mice (n = 10 per group) were treated intraperitoneally with OI (50 mg kg−1) in 40% cyclodextrin in PBS or vehicle control for 2 h before stimulation with LPS (5 mg kg−1) and monitored for temperature at 1, 2, 3, 4, 6, 12, 18 and 24 h after LPS treatment. Temperature was monitored using subcutaneously implanted temperature transponder chips (Bio Medic Data Systems; IPTT 300) which were injected between the shoulder blades 48 h before experiment. At defined times, body temperature was measured by scanning the transponder with a corresponding BMDS Smart Probe. Animals were additionally monitored for clinical signs of endotoxic shock, based on temperature change, body condition, physical condition and unprovoked behaviour, with a combined score of 9 indicating the humane end point for the experiment.
+ Open protocol
+ Expand

Corresponding organizations : Trinity College Dublin, MRC Mitochondrial Biology Unit, University of Cambridge, University of Dundee, Harvard University, Dana-Farber Cancer Institute, MRC Cancer Unit, Hutchison/MRC Research Centre, University of Oxford, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (Germany), University of Glasgow

3

Investigating Oral Sensitization and Anaphylaxis

Mice were treated intragastrically with either sterile PBS or OVA (Sigma-Aldrich) (250μg) together with 10μg SEB (Toxin Technology) in PBS (Treg) once weekly for 8 weeks. In some experiments, mice were gavaged with SEB (10 μg) alone. On week 9, mice were challenged intragastrically with 150 mg of OVA. Anaphylaxis was assessed by measuring changes in total body core temperature with transponders placed subcutaneously 2 days before challenge (IPTT-300; Bio Medic Data Systems) and a DAS-6001 console (Bio Medic Data Systems).
+ Open protocol
+ Expand

Corresponding organizations : Harvard University, Boston Children's Hospital, Children's Hospital of Los Angeles

4

Amphetamine Exposure Protocol in Rats

On the day of mAMPH injections, rats were kept in large, clear Plexiglas cages measuring 40 cm (length) × 40 cm (width) × 38 cm (height) in groups of no more than seven animals each. Ambient room temperature was kept at 23 ± 1.5 °C. Rats were given injections of d-mAMPH (Sigma, St. Louis, MO; 2 mg free base/kg, sc) or physiological saline solution (SAL; 1 ml/kg, sc) at two hour intervals for a total of four injections. This dose was chosen to minimize motor impairments and to circumvent any stress response produced by an interaction with food restriction, given the known deleterious effects of stress on behavioral flexibility (Holmes and Wellman, 2008 (link)). Animal body temperatures were monitored 60 min after each injection: by rectal probe (Experiment 1) or by temperature transponders (IPTT-300; BioMedic Data Systems, Seaford, DE) implanted subcutaneously along the dorsum between the animals’ scapula the day prior to drug treatments (Experiment 2); Table 1.
+ Open protocol
+ Expand

Corresponding organizations : California State University Los Angeles, University of California, Irvine

5

Rat Model of Rift Valley Fever Virus Infection

Age-matched nonpregnant and time-mated SD rats (6 to 8 weeks) were obtained from Envigo Laboratories. A positive copulation plug verified pregnancy for early-gestation [embryonic day 5 (E5)] and late-gestation (E14) females. All pregnant rats were delivered to individual cages, and nonpregnant rats were housed three to a cage in temperature-controlled rooms with a 12-hour day/12-hour night light schedule. Food (IsoPro Rodent 3000) and water were provided ad libitum. Rats were implanted with programmable temperature transponders (IPTT-300, Bio Medic Data Systems) subcutaneously between the shoulder blades. For infection, all rats were anesthetized by inhalation of isoflurane vapors (IsoThesia, Henry Schein) and inoculated subcutaneously in the hind flank with 500 μl of RVFV diluted in D2 medium. Weight and body temperature were recorded daily starting the day of infection. In addition, each animal was closely monitored twice daily for the development of clinical signs. Endpoint criteria, which prompt immediate euthanasia, were defined on the basis of weight, temperature, appearance, and behavioral scoring parameters. Once euthanasia criteria were met, rats were anesthetized by inhalation of isoflurane vapors, followed by an immediate blood draw and euthanasia by cardiac puncture.
Rats were inoculated on E14 with the following doses of RVFV strain ZH501: 7.5 × 101 PFU (n = 5), 1.8 × 102 PFU (n = 6), 1.5 × 103 PFU (n = 11), and 2.6 × 104 PFU (n = 6). Unless dams met euthanasia criteria, they progressed to full-term and delivered pups on E22 [8 days postinfection (dpi)]. After delivery, dams and pups were not disturbed until 5 days postdelivery (13 dpi) to reduce stress. Added stress on the dams can lead to consumption of newborn pups by dam (17 ). Weight monitoring of pups began on neonatal day 5 (13 dpi) until 18 dpi when both dam and pups were euthanized at the predetermined end of the study (Fig. 1A).
One rat at E5 was infected with 1.5 × 105 PFU of RVFV. A noninfected dam at E5 gestation was observed in parallel. Dams were euthanized at a predetermined date of 7 dpi, corresponding to E13.
Age-matched nonpregnant rats were inoculated with the following doses of RVFV strain ZH501: 3.1 × 103 PFU (n = 11), 3.5 × 104 PFU (n = 5), and 1.3 × 105 PFU (n = 6). Unless the nonpregnant rats met euthanasia criteria and were euthanized, the rats were euthanized at a predetermined end date of the study at 16 dpi.
Upon necropsy, tissues were harvested and suspended in 2× weight/volume D2 media and homogenized using an Omni tissue homogenizer (Omni International). Tissue homogenates were used to quantitate infectious virus by VPA inside the BSL-3 facility. For quantitation of RVFV-specific viral RNA (vRNA) by quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis, 100 μl of each tissue homogenate was inactivated in 900 μl of Tri-Reagent (Invitrogen) for 10 min before removal from the BSL-3 facility. Subsequent storage at −80°C or RNA isolation and qRT-PCR analyses occurred in a BSL-2 setting.
+ Open protocol
+ Expand

Corresponding organizations : University of Pittsburgh, University of Alabama at Birmingham, Magee-Womens Hospital, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh

The spelling variants listed above correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Protocol search & design
(papers, patents, application notes)
2. Protocol validation
(from literature and MDAR)
3. Lab Product search
4. Product validation from literature
5. Troubleshoot product/ protocol
6. Instant figure generation New
Want to copy this response? Create your account to unlock copy/paste and export options.